Showing results (131-140 of 432) with videos related to

Sort By:
Pageof 44
Endocrine|November 19, 2017
Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter studyDavide Campana, Thomas Walter, Sara Pusceddu, et al.
Cancers|June 19, 2024
Emerging Treatment Options for Neuroendocrine Neoplasms of Unknown Primary Origin: Current Evidence and Future PerspectivesFrancesca Corti, Roberta Elisa Rossi, Pietro Cafaro, et al.
Anticancer Research|November 14, 2013
A retrospective analysis of two different sequences of therapy lines for advanced kidney cancerChiara Paglino, Giuseppe Procopio, Roberto Sabbatini, et al.
Tumori|August 29, 2025
Medication-related jaw osteonecrosis in metastatic RCC treated with VEGFR-TKIs ± IO and bone agents: A real-world analysisMarco Stellato, Ernesto Zecca, Paola Bracchi, et al.
Cancer Treatment Reviews|March 18, 2022
Current evidence for second-line treatment in metastatic renal cell carcinoma after progression to immune-based combinationsRoberto Iacovelli, Chiara Ciccarese, Giuseppe Procopio, et al.
BJU International|March 13, 2012
The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changesTiziana Magnani, Riccardo Valdagni, Roberto Salvioni, et al.
Critical Reviews in Oncology/Hematology|July 4, 2016
Immunotherapy advances in uro-genital malignanciesRaffaele Ratta, Roberta Zappasodi, Daniele Raggi, et al.
Case Reports in Oncology|October 11, 2016
Primary Cerebellar Neuroendocrine Tumors: Chimeras or Real Entities? A Case Report with a 6-Year Follow-UpClaudio Vernieri, Daniela Femia, Sara Pusceddu, et al.
Pharmacotherapy|December 26, 2022
Is ketamine infusion effective and safe as an adjuvant of sedation in the PICU? Results from the Ketamine Infusion Sedation Study (KISS)Anna Tessari, Francesca Sperotto, Federico Pece, et al.
Breast (Edinburgh, Scotland)|September 7, 2018
Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer: An indication to immunotherapy?Anna Tessari, Lorenzo Pilla, Damian Silvia, et al.
Pageof 44